Prestige Biopharma's First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval ...

Retrieved on: 2021-06-20 23:26:15

Tags for this article:

Click the tags to see associated articles and topics

Prestige Biopharma's First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval .... View article details on hiswai:

Excerpt

Prestige BioPharma's anti-PAUF antibody PBP1510 is envisioned to provide significant benefit in all patients affected by PAUF-positive pancreatic ...

Article found on: finance.yahoo.com